POLICY BRIEFINGS

Eli Lilly Requests EUA for Monoclonal Antibody Treatment


Eli Lilly is requesting the Food and Drug Administration (FDA) issue an emergency use authorization (EUA) for its coronavirus monoclonal antibody treatment known as bamlanivimab. The company seeks to use the treatment on high-risk patients recently diagnosed with mild-to-moderate COVID-19. According to data from its phase II clinical trial published by the company, patients who received any dose of the antibody were less likely to be hospitalized or visit the emergency room. A phase III study for the prevention of COVID in residents and staff at long-term care (LTC) facilities is ongoing. If Eli Lilly receives the EUA, it says it could supply as many as one million doses before the end of the year. The company plans to ask for an emergency authorization for its combination monoclonal antibody treatment next month.


Hart Health Strategies COVID-19 Resources


Hart Health Strategies Inc. continues to update the following resources related to the coronavirus pandemic. Please remember to clear your cache to ensure you download the most recent documents.


Recently Introduced Health Legislation


H.Res.1176 —Supporting the designation of October 3, 2020, as National Ostomy Awareness Day; Sponsor: Rep. Payne, Donald M., Jr. [D-NJ-10]; Committees: House - Oversight and Reform

H.R.8505 —To amend title XVIII of the Social Security Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare physician fee schedule, and for other purposes; Sponsor: Rep. Burgess, Michael C. [RTX-26]; Committees: House - Ways and Means; Energy and Commerce; Appropriations

H.R.8506 —To improve the provision of health care and other benefits from the Department of Veterans Affairs for veterans who were exposed to toxic substances, and for other purposes; Sponsor: Rep. Bilirakis, Gus M. [R-FL-12]; Committees: House - Veterans’ Affairs

H.R.8508 —To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of the supplies necessary for distributing and administering the COVID-19 vaccine, and for other purposes; Sponsor: Rep. Crist, Charlie [D-FL-13]; Committees: House - Financial Services

H.R.8525 — To amend title XIX of the Social Security Act to provide for coverage under the Medicaid program of noninvasive prenatal genetic screening; Sponsor: Rep. Speier, Jackie [D-CA-14]; Committees: House - Energy and Commerce

H.R.8527 —To address the high costs of health care services, prescription drugs, and health insurance coverage in the United States, and for other purposes; Sponsor: Rep. Westerman, Bruce [R-AR-4]; Committees: House - Ways and Means; Rules; Judiciary; Energy and Commerce; House Administration; Oversight and Reform; Education and Labor; Budget; Armed Services

H.R.8528 —To extend certain provisions relating to telehealth services, and for other purposes; Sponsor: Rep. Williams, Roger [R-TX-25]; Committees: House - Ways and Means; Energy and Commerce

S.4796 — A bill to address the high costs of health care services, prescription drugs, and health insurance coverage in the United States, and for other purposes; Sponsor: Sen. Braun, Mike [R-IN]; Committees: Senate – Finance

H.Res.1181 — Honoring Rosalynn Smith Carter’s 50 years of mental health advocacy; Sponsor: Rep. Dingell, Debbie [D-MI-12];Committees: House - Energy and Commerce

H.Res.1182 — Recognizing the roles and the contributions of America’s certified nurse-midwives and certified midwives in providing high-quality, evidence-based, cost-effective, and essential sexual and reproductive health care services to women and pregnant people; Sponsor: Rep. Roybal-Allard, Lucille [D-CA-40]; Committees: House - Energy and Commerce

H.R.8529 — To amend title XIX of the Social Security Act to prohibit additional rebates under the Medicaid program for certain noninnovator multiple source drugs; Sponsor: Rep. Butterfield, G. K. [D-NC-1]; Committees: House - Energy and Commerce

H.R.8536 — To amend the Fair Credit Reporting Act to delay the reporting of medical debt by consumer reporting agencies, and for other purposes; Sponsor: Rep. Gallagher, Mike [R-WI-8]; Committees: House - Financial Services

H.R.8546 — To amend titles XIX and XXI of the Social Security Act to give States the option to extend the Medicaid drug rebate program to the Children’s Health Insurance Program, and for other purposes; Sponsor: Rep. Wild, Susan [D-PA7]; Committees: House - Energy and Commerce



October 12, 2020: | Page 1 Page 2 Page 3

SERVICES



BRIEFING ARCHIVE

 -  2023

 +  2022

 +  2021

 +  2020

 +  2019

 +  2018